EUVIMEDEUVIMED entdecken
Open Access

DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma

Jingchun Wang, Yu Chen, Yanquan Xu, Jiangang Zhang, Shuai Yang, Yu Zhou, Juan Lei, Ran Ren, Yang Chen, Huakan Zhao, Yongsheng Li, Shiming Yang

Theranostics · 2024 · 14 (17) · 6798-6817

DOI: 10.7150/thno.102995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Jingchun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Second Affiliated Hospital, Army Medical University; Chongqing 400037, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sorafenib, Endodeoxyribonucleases. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsSorafenibEndodeoxyribonucleasesHumansAnimalsMiceCell Line, TumorImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsFemaleProgrammed Cell Death 1 ReceptorMaleApoptosisXenograft Model Antitumor AssaysProteomics

Stichwörter der Autor:innen

DNASE1L3PANoptosisadvanced hepatocellular carcinomacombination therapy

Substanzen

SorafenibEndodeoxyribonucleasesDNASE1L3 protein, humanImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Second Affiliated Hospital, Army Medical University; Chongqing 400037, China.
  • Department of Medical Oncology, Chongqing University Cancer Hospital; Chongqing 400030, China.
  • Clinical Medicine Research Center, Second Affiliated Hospital, Army Medical University; Chongqing 400037, China.
  • Department of Pathology, First Affiliated Hospital, Army Medical University; Chongqing 400037, China.

Zitieren

APA

Wang, J., Chen, Y., Xu, Y., Zhang, J., Yang, S., Zhou, Y., Lei, J., Ren, R., Chen, Y., Zhao, H., Li, Y., & Yang, S. (2024). DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma. Theranostics, 14(17), 6798-6817. https://doi.org/10.7150/thno.102995

Vancouver

Wang J, Chen Y, Xu Y, Zhang J, Yang S, Zhou Y, et al. DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma. Theranostics. 2024;14(17):6798-6817. doi:10.7150/thno.102995

BibTeX
@article{Wang2024,
  author = {Wang, Jingchun and Chen, Yu and Xu, Yanquan and Zhang, Jiangang and Yang, Shuai and Zhou, Yu and Lei, Juan and Ren, Ran and Chen, Yang and Zhao, Huakan and Li, Yongsheng and Yang, Shiming},
  title = {DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {17},
  pages = {6798--6817},
  doi = {10.7150/thno.102995}
}
Kostenlos starten →